Wyeth Sets Webcast and Conference Call For 2009 Second Quarter Earnings

MADISON, N.J., June 10 /PRNewswire-FirstCall/ -- On Thursday, July 23, 2009,
Wyeth (NYSE: WYE) will announce financial results for the 2009 second quarter.
The Company will hold a conference call with research analysts at 8:00 a.m.
Eastern Time on July 23, 2009.

Interested investors and others may listen to the call live or on a delayed
basis through our Internet webcast, which may be accessed by visiting our
website at www.wyeth.com and clicking on the "Investor Relations" icon.

Wyeth is one of the world's largest research-driven pharmaceutical and health
care products companies. It is a leader in the discovery, development,
manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology
products, and non-prescription medicines that improve the quality of life for
people worldwide. The Company's major divisions include Wyeth
Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.

The statements in this press release that are not historical facts are
forward-looking statements that are subject to risks and uncertainties that
could cause actual results to differ materially from those expressed or
implied by such statements. These risks and uncertainties include, among
others, risks related to our proposed merger with Pfizer, including
satisfaction of the conditions of the proposed merger on the proposed
timeframe or at all, contractual restrictions on the conduct of our business
included in the merger agreement, and the potential for loss of key personnel,
disruption in key business activities or any impact on our relationships with
third parties as a result of the announcement of the proposed merger; the
inherent uncertainty of the timing and success of, and expense associated
with, research, development, regulatory approval and commercialization of our
products and pipeline products; government cost-containment initiatives;
restrictions on third-party payments for our products; substantial competition
in our industry, including from branded and generic products; emerging data on
our products and pipeline products; the importance of strong performance from
our principal products and our anticipated new product introductions; the
highly regulated nature of our business; product liability, intellectual
property and other litigation risks and environmental liabilities; the outcome
of government investigations; uncertainty regarding our intellectual property
rights and those of others; difficulties associated with, and regulatory
compliance with respect to, manufacturing of our products; risks associated
with our strategic relationships; global economic conditions; interest and
currency exchange rate fluctuations and volatility in the credit and financial
markets; changes in generally accepted accounting principles; trade buying
patterns; the impact of legislation and regulatory compliance; risks and
uncertainties associated with global operations and sales; and other risks and
uncertainties, including those detailed from time to time in our periodic
reports filed with the Securities and Exchange Commission, including our
current reports on Form 8-K, quarterly reports on Form 10-Q and annual report
on Form 10-K, particularly the discussion under the caption "Item 1A, Risk
Factors" in our Annual Report on Form 10-K for the year ended December 31,
2008, which was filed with the Securities and Exchange Commission on February
27, 2009. The forward-looking statements in this press release are qualified
by these risk factors. We assume no obligation to publicly update any
forward-looking statements, whether as a result of new information, future
developments or otherwise.

SOURCE Wyeth

Media, Douglas Petkus, +1-973-660-5218, or Investors, Justin Victoria,
+1-973-660-5340, both for Wyeth